Suppression of Puerperal Lactation with an Ergot Alkaloid: A Double-blind Study

Authors:
  • LVL. Varga
    L. Varga
  • PLP. M. Lutterbeck
    P. M. Lutterbeck
  • JPJ. S. Pryor
    J. S. Pryor
  • RWR. Wenner
    R. Wenner
  • HEH. Erb
    H. Erb

Abstract
A double-blind trial was performed in 60 women to establish the effectiveness of an ergot alkaloid, 2-Br-alpha-ergocryptine (ergocryptine; CB 154), in suppressing puerperal lactation and to compare it with stilboestrol and a placebo. At the doses selected ergocryptine and stilboestrol were equally effective.